Cargando…

Improving VTE risk assessment at point of admission to a tertiary centre cardiology ward

Cardiology wards are generally high turnover units, which may receive primary PCI, high-risk NSTEMI patients, and other general cardiac admissions from a large geographical area. Many centres also provide national specialist services for rarer cardiac conditions for which admissions may be lengthy....

Descripción completa

Detalles Bibliográficos
Autor principal: Wilson, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: British Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693033/
https://www.ncbi.nlm.nih.gov/pubmed/26734384
http://dx.doi.org/10.1136/bmjquality.u209203.w3760
_version_ 1782407308700024832
author Wilson, Rachel
author_facet Wilson, Rachel
author_sort Wilson, Rachel
collection PubMed
description Cardiology wards are generally high turnover units, which may receive primary PCI, high-risk NSTEMI patients, and other general cardiac admissions from a large geographical area. Many centres also provide national specialist services for rarer cardiac conditions for which admissions may be lengthy. Cardiac patients have significant risk factors for venous thromboembolism (VTE) as immobility may be due to systolic dysfunction, attachment to continuous monitoring and predisposition to chest pain, or cardiac syncope. It is recommended by NICE that an initial VTE risk assessment is undertaken at the time of patient admission, with reassessment within 24 hours. For this purpose a risk assessment tool is featured on the front of many Trust drug charts. It is noted that this risk assessment is electronic in other trusts. We undertook an audit into the drug chart documentation of VTE risk assessment on the cardiology ward and the Coronary Care Unit (CCU) at The Royal Free Hospital. It was evident that documentation of VTE risk assessment was poor. The audit interventions were; a teaching presentation to the cardiology department, an educational poster, several update emails to the department and the identification of a ‘VTE risk assessment champion’ to audit ongoing compliance. Following these measures the second audit round demonstrated that documentation of initial risk assessment was slightly improved, but significant improvement was seen in documentation of risk assessment at 24 hours post admission. Results from a third audit cycle indicated that the improvement in initial VTE risk assessment was sustained, and that there was a significant sustained improvement in risk assessment at 24 hours (p <0.05). Recommendations for sustained improvement included: redesigning the drug chart so that the VTE risk assessment tool was linked to the VTE prophylaxis prescription box, and designating the responsibility of the initial VTE risk assessment to the on call junior doctor who receives admissions on to the ward.
format Online
Article
Text
id pubmed-4693033
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher British Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46930332016-01-05 Improving VTE risk assessment at point of admission to a tertiary centre cardiology ward Wilson, Rachel BMJ Qual Improv Rep BMJ Quality Improvement Programme Cardiology wards are generally high turnover units, which may receive primary PCI, high-risk NSTEMI patients, and other general cardiac admissions from a large geographical area. Many centres also provide national specialist services for rarer cardiac conditions for which admissions may be lengthy. Cardiac patients have significant risk factors for venous thromboembolism (VTE) as immobility may be due to systolic dysfunction, attachment to continuous monitoring and predisposition to chest pain, or cardiac syncope. It is recommended by NICE that an initial VTE risk assessment is undertaken at the time of patient admission, with reassessment within 24 hours. For this purpose a risk assessment tool is featured on the front of many Trust drug charts. It is noted that this risk assessment is electronic in other trusts. We undertook an audit into the drug chart documentation of VTE risk assessment on the cardiology ward and the Coronary Care Unit (CCU) at The Royal Free Hospital. It was evident that documentation of VTE risk assessment was poor. The audit interventions were; a teaching presentation to the cardiology department, an educational poster, several update emails to the department and the identification of a ‘VTE risk assessment champion’ to audit ongoing compliance. Following these measures the second audit round demonstrated that documentation of initial risk assessment was slightly improved, but significant improvement was seen in documentation of risk assessment at 24 hours post admission. Results from a third audit cycle indicated that the improvement in initial VTE risk assessment was sustained, and that there was a significant sustained improvement in risk assessment at 24 hours (p <0.05). Recommendations for sustained improvement included: redesigning the drug chart so that the VTE risk assessment tool was linked to the VTE prophylaxis prescription box, and designating the responsibility of the initial VTE risk assessment to the on call junior doctor who receives admissions on to the ward. British Publishing Group 2015-08-19 /pmc/articles/PMC4693033/ /pubmed/26734384 http://dx.doi.org/10.1136/bmjquality.u209203.w3760 Text en © 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/http://creativecommons.org/licenses/by-nc/2.0/legalcode
spellingShingle BMJ Quality Improvement Programme
Wilson, Rachel
Improving VTE risk assessment at point of admission to a tertiary centre cardiology ward
title Improving VTE risk assessment at point of admission to a tertiary centre cardiology ward
title_full Improving VTE risk assessment at point of admission to a tertiary centre cardiology ward
title_fullStr Improving VTE risk assessment at point of admission to a tertiary centre cardiology ward
title_full_unstemmed Improving VTE risk assessment at point of admission to a tertiary centre cardiology ward
title_short Improving VTE risk assessment at point of admission to a tertiary centre cardiology ward
title_sort improving vte risk assessment at point of admission to a tertiary centre cardiology ward
topic BMJ Quality Improvement Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693033/
https://www.ncbi.nlm.nih.gov/pubmed/26734384
http://dx.doi.org/10.1136/bmjquality.u209203.w3760
work_keys_str_mv AT wilsonrachel improvingvteriskassessmentatpointofadmissiontoatertiarycentrecardiologyward